Australia's most trusted
source of pharma news
Monday, 15 June 2026
Monday, 15 June 2026
Subscribe
Login
News Headlines
News Headlines
News
TGA registers three new drugs
Posted 15 June 2026 AM
Three new drugs have hit the ARTG, all targeting rare diseases and two affecting RNA.
Otsuka's Zirdawny has been approved for routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older, and is an RNA-targeted medicine designed to target plasma prekallikrein (PKK), which plays an important role in activating inflammatory mediators associated with acute attacks of HAE.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (22)
- Senior Sales Manager - Sydney
- Account Manager - Sydney
- Clinical Account Manager - Melbourne
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
- Territory Manager - Melbourne
- Key Account Manager - Melbourne
- Senior Group Financial Accountant - Victoria
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Strategic Sales Director ANZ, Digital Health - Sydney
- Sales Manager / Territory Manager - Christchurch
- Business Development Manager – Health Tech - Melbourne
- Business Development Manager – Health Tech - Brisbane
- GP Representative - Geelong
- Business Development Manager, Health Tech - Sydney
- Territory Manager - Gold Coast
- Sales Director - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (8)
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Clinical Trial Investigator - Melbourne
- Senior Medical Manager - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
Regulatory, Pharmacovigilance & QA (3)
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Other (10)
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
- Manufacturing Process Engineer - Blacktown
- QC Analyst - Microbiology - Melbourne
- Lab Technician - Victoria
- Senior Recruitment Consultant - Victoria
- Talent Acquisition Coordinator - Mascot
- Portfolio Manager ANZ - Melbourne
- Director of Operations, HealthTech - Melbourne
- Talent Acquisition Coordinator - Mascot
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.